Contact Information
Company Information
Company
AiCuris Anti-infective Cures AG
Annual Revenue
10200000.0
Technologies
Outlook
Microsoft Office 365
Apache
Google Font API
Mobile Friendly
Google Analytics
Google Tag Manager
WordPress.org
Remote
Keywords
antiinfectives
virology
preclinical & clinical development
biotechnology research
antiviral therapies
immunocompromised patients
clinical trials
drug resistance
herpes simplex virus
aic468
pritelivir
bk virus
early access program
innovative treatment
viral infections
infectious diseases
therapeutic candidates
safety & efficacy
medical innovation
antiviral solutions
life-threatening infections
targeted therapies
antiviral agents
fda approval
prevention of cmv
cytomegalovirus
kidney transplant
breakthrough therapy
infectious disease unit
patient-first approach
transforming transplantation medicine
late-stage product candidate
clinical development
preclinical studies
oral antiviral
patient population
expanded access
medical need
thymidine kinase
direct acting antivirals
immunosuppressive therapy
research & development
therapeutic innovations
high-risk patients
pharmaceutical r&d
immune deficiency
biologics development
rna therapeutics
patient safety
transplant care
clinical research
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans